Anita W. Asgar, MD, director, transcatheter valve therapy research at Montréal Heart Institute, discusses advances and new technology for mitral and tricuspid valves at the 2022 Transcatheter Valve Therapies (TVT) meeting. 

The study's authors explored data from 35 patients who received the TricValve Transcatheter Bicaval Valves System. All patients presented with severe tricuspid regurgitation.

Treating subclinical leaflet thrombosis after TAVR has been an ongoing challenge for structural heart clinicians, but recent research has gone a long way toward improving our understanding of this important topic. 

“Robotically assisted mitral valve surgery allows us to make even smaller incisions with greater precision,” one surgeon said. “By using the robotic arms, we have more degrees of articulation than with our natural wrists."

Anita Asgar, MD, discusses a free textbook available online she co-edited on the transcatheter edge-to-edge repair (TEER) of the mitral valve.